Bohan Ma
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
-
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- Chemical Synthesis and Analysis
Papers in
-
- Protein Degradation and Inhibitors 12
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 2
- RNA Interference and Gene Delivery 1
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Yongping Shao (8 shared papers)Wuyuan Lu (6 shared papers)Wangxiao He (5 shared papers)Jin Yan (4 shared papers)F. Niu (3 shared papers)Peter X. Ma (3 shared papers)Yizeng Fan (10 shared papers)Lei Li (10 shared papers)
- Journals
- Nature Communications (4 papers)Advanced Science (3 papers)Biochemical and Biophysical Research Communications (2 papers)Advanced Materials (2 papers)Chemical Engineering Journal (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bohan Ma
32 papers receiving 973 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 237
- Molecular Biology 386
- Biomedical Engineering 168
- Oncology 92
- Pharmaceutical Science 25
Countries citing papers authored by Bohan Ma
This map shows the geographic impact of Bohan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bohan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bohan Ma more than expected).
Fields of papers citing papers by Bohan Ma
This network shows the impact of papers produced by Bohan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bohan Ma. The network helps show where Bohan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bohan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 126 | |
| 2 | 2017 | 116 | |
| 3 | 2022 | 76 | |
| 4 | 2018 | 69 | |
| 5 | 2017 | 68 | |
| 6 | 2021 | 65 | |
| 7 | 2022 | 47 | |
| 8 | 2018 | 44 | |
| 9 | 2019 | 37 | |
| 10 | 2022 | 30 | |
| 11 | 2019 | 28 | |
| 12 | 2022 | 28 | |
| 13 | 2024 | 28 | |
| 14 | 2024 | 25 | |
| 15 | 2024 | 25 | |
| 16 | 2018 | 23 | |
| 17 | 2022 | 23 | |
| 18 | 2023 | 20 | |
| 19 | 2023 | 18 | |
| 20 | 2024 | 17 |
About Bohan Ma
Bohan Ma is a scholar working on Molecular Biology, Biomaterials, Oncology, Pulmonary and Respiratory Medicine and Endocrinology, having authored 33 papers that have together received 988 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (12 papers), Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (3 papers), DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers), Ubiquitin and proteasome pathways (2 papers), Ferroptosis and cancer prognosis (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Biomaterials (237 citations), Molecular Biology (386 citations), Biomedical Engineering (168 citations), Oncology (92 citations) and Pharmaceutical Science (25 citations). Bohan Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yongping Shao, Wuyuan Lu, Wangxiao He, Jin Yan, F. Niu, Peter X. Ma, Yizeng Fan, Lei Li, Yang Gao and Bo Lei. Their work appears in journals such as Nature Communications, Advanced Science, Biochemical and Biophysical Research Communications, Advanced Materials and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.